Hormone Optimization and Wellness in Modern Medicine

Hormone Optimization, TRT, and Wellness

Abstract

This comprehensive educational post explores the intricate world of hormonal health and patient-centered care, drawing from my extensive clinical experience as a practitioner with a diverse background in chiropractic (DC), advanced practice nursing (APRN, FNP-BC), and functional medicine (CFMP, IFMCP). I will guide you through the essential systems and physiological principles necessary for successful treatment outcomes in complex cases. We will delve into the critical differences among hormone delivery methods, debunk myths about Hormone Replacement Therapy (HRT) and thrombosis risk, and explore the nuances of Testosterone Replacement Therapy (TRT), including managing side effects such as aromatization, erythropoiesis, and hair loss. Key topics also include patient management strategies, the diagnostic significance of endometrial assessment, the dangers of superbugs such as MRSA, and the pharmacology of common medications. This post integrates evidence-based findings with my clinical observations to provide a holistic approach to optimizing patient care, emphasizing that integrative chiropractic care offers a foundational framework for enhancing nervous system function, supporting musculoskeletal integrity, and improving overall well-being.

The Foundation of a Successful Practice: Prioritizing Patient Goals

In my many years of clinical practice, one of the most profound lessons I’ve learned is the power of listening. Success in patient care hinges not just on what you know, but on how you apply it. Creating a robust, systematic approach is paramount. It’s the difference between chaotic, unpredictable outcomes and a streamlined process that ensures every patient receives the highest standard of care.

When a new patient walks into my clinic, they bring with them a unique story and a set of health concerns. While my diagnostic tools and lab results can reveal dozens of physiological imbalances, the patient’s perceived priorities are what truly guide our therapeutic journey. This is why my initial consultation always begins with a simple yet powerful question: “Can you list, in order of priority, the top three things you want to address?”

These three goals become our “problems to solve” and the benchmarks against which we will measure success. This patient-centered approach ensures that our efforts are aligned with their needs, fostering a strong therapeutic alliance and leading to more meaningful outcomes. It’s about treating the person, not just the symptom list.

• Initial Consultation: We review the system, explain the process, and gather all necessary information, with a focus on their top 3 goals.
• Follow-Up Visits: We review progress, adjust the plan, and schedule the next appointment before the patient leaves. Our goal is for 90% of patients to have their next visit scheduled upon checkout. This ensures continuity of care and keeps patients engaged and accountable.
• Patient Retention: Keeping patients on schedule is critical to ensuring they achieve their health goals. A patient who disappears for months is unlikely to see the results they desire.

This system isn’t just about efficiency; it’s about building trust and demonstrating to the patient that you have a clear, intentional plan for their health journey.

Debunking the Myths: Hormone Therapy and Blood Clot Risk

One of the most persistent concerns I encounter in my practice revolves around the risk of blood clots, or venous thromboembolism (VTE), associated with Hormone Replacement Therapy (HRT). For years, a cloud of uncertainty has surrounded these treatments, causing many patients to endure a diminished quality of life. It’s time to bring clarity to this topic, guided by robust scientific evidence.

The crucial takeaway from decades of research is this: the method of hormone delivery is paramount.

The Critical Difference: Oral vs. Non-Oral Hormones

The consensus from numerous large-scale studies and meta-analyses is clear. Leading medical journals all point to the same conclusion:

• Transdermal and other non-oral forms of HRT (patches, creams, gels, pellets, injections) do not show a statistically significant increase in the risk of blood clots (Vinogradova et al., 2019).
• Oral estrogens, in contrast, are processed through the liver in what is called the “first-pass effect.” This hepatic metabolism can increase clotting factor production, thereby elevating the risk of thrombosis.

This distinction is the central pillar of safe and effective hormone therapy. When hormones are absorbed directly into the bloodstream through the skin or muscle, they bypass first-pass hepatic metabolism, thereby avoiding stimulation of prothrombotic factors.

A landmark study published in the British Medical Journal involving over 80,000 women provided powerful evidence for this distinction. The research found no significant increase in the risk of blood clots among users of non-oral HRT (Vinogradova et al., 2019). The data were so compelling that they have fundamentally shifted modern clinical practice.

My Clinical Protocol: Safety First

Based on this overwhelming evidence, my approach is unequivocal.

• For new patients requiring HRT, I exclusively initiate treatment with non-oral methods. I have not started a new patient on oral estrogen for this purpose in over a decade. The safety profile is simply superior.
• For existing patients who have been stable on low-dose oral estrogen for many years, the approach is one of shared decision-making. I will have a detailed conversation, explaining the small but real increased risk and discussing the benefits of switching to a safer, transdermal alternative. The final decision rests with the patient, but it must be an informed one.

As a clinician, I refuse to let a patient suffer from a debilitatingly poor quality of life because of an exaggerated fear of a preventable risk. We have the tools and the knowledge to provide these life-changing therapies safely.

Personalized Hormone Therapy: Navigating the Nuances of TRT and Progesterone

A significant part of my practice involves hormone replacement therapy. Understanding the physiological effects of different hormones and delivery methods is crucial for tailoring treatment to the individual.

The Pitfalls of Short-Acting Testosterone Therapies

I frequently encounter patients who have been on a frustrating journey with Testosterone Replacement Therapy (TRT) using short-acting methods like topical creams. The fundamental issue is their pharmacokinetic profile, which creates a volatile “spike-and-trough” cycle.

When you apply a testosterone cream, you get a rapid, high spike in blood testosterone levels, which then plummets just a few hours later. This rapid fluctuation is not just ineffective; it can be detrimental.

• Inflammatory Response: High spikes in testosterone can trigger an inflammatory cascade by increasing the number and sensitivity of interleukin receptors, leading to a pro-inflammatory state.
• Lack of Efficacy: Patients experience a return of their original symptoms—fatigue, low libido, brain fog—as levels drop, leading to a hormonal roller coaster.
• Side Effects: The volatile cycle is when many side effects manifest, such as acne and an increased risk of polycythemia.

My goal is to avoid these peaks and valleys. I prefer long-acting modalities like testosterone pellets, which are implanted subcutaneously and release the hormone slowly over several months. This maintains a steady physiological state, maximizing benefits while minimizing risks. Transitioning a patient from injections to pellets requires careful management, as they may initially miss the “kick” from an injection. In about 15% of cases, I may blend the transition with a small dose of a faster-acting form to smooth the process.

The Clinical Application of Progesterone

Progesterone is another versatile tool, but its application is far from one-size-fits-all.

• Progesterone for Sleep: One of the most valued “side effects” of oral progesterone is its conversion in the liver to allopregnanolone. This metabolite acts on GABA-A receptors in the brain, producing a calming, sedative effect. This is why oral progesterone can be a game-changer for women struggling with insomnia. It is critical to note that this sedative effect is unique to the oral route. Sublingual or transdermal progesterone bypasses this first-pass metabolism and will not produce the same sleep-promoting metabolites.
• Progesterone for Abnormal Bleeding: For a patient experiencing abnormal or heavy uterine bleeding, we often use progesterone to stabilize the endometrial lining, allowing us to investigate the underlying cause.

I often rely on trusted compounding pharmacies to create specific formulations, such as a 200 mg oral capsule, which I find effective for about 95% of my patients who require it for sleep.

Managing Common Side Effects of Testosterone Therapy

Just as with female hormones, TRT in men is surrounded by its own set of myths and clinical challenges. Two of the most common physiological responses we must manage are aromatization and erythropoiesis.

The Estrogen Spike: A Temporary and Manageable Phenomenon

When a man starts TRT, his body can experience a temporary, sharp rise in estrogen levels. This happens because the aromatase enzyme converts the newly influxed testosterone into estradiol. This is a transient effect. The body is reacting to the significant change from a low- to a high-testosterone state. In most cases, if you do nothing, the body will self-regulate, and estrogen levels will naturally decline to a normal ratio.

Intervening too quickly with an aromatase inhibitor can disrupt this natural feedback loop. My approach is to wait and re-test. I only consider an aromatase inhibitor if the patient has persistent symptoms of high estrogen. We must treat the patient, not just the lab number.

Red Blood Cells and Polycythemia: Distinguishing Physiology from Pathology

One of the fundamental effects of testosterone is the stimulation of erythropoiesis, the process of creating new red blood cells. This is a normal, expected physiological response. This is often confused with a dangerous blood cancer called Polycythemia Vera (PV).

• Secondary Polycythemia: This is what occurs with TRT. It is a dose-dependent increase in red blood cells driven by a normal physiological process.
• Polycythemia Vera (PV): This is a bone marrow cancer characterized by an uncontrolled overproduction of red blood cells independent of normal signaling.

A man on TRT who develops a high hematocrit has a predictable and manageable side effect. If a patient’s hematocrit becomes too high (e.g., over 54%), the solution is to lower the testosterone dose. This side effect is 100% dose-related and 100% reversible.

The Connection Between Testosterone, DHT, and Hair Loss

Another common concern is hair loss. Testosterone itself does not cause hair loss; the real culprit is a metabolite called Dihydrotestosterone (DHT).

• The Role of 5-Alpha-Reductase: This enzyme converts testosterone into DHT.
• Genetic Predisposition: Hair loss occurs in individuals with a genetic predisposition for androgenetic alopecia. In these individuals, the hair follicles are genetically sensitive to DHT, which causes them to shrink over time.

This is why I always check DHT levels as part of my comprehensive workup to monitor this conversion. It is also important to distinguish between this genetic hair loss and normal shedding. When testosterone levels are optimized, the hair growth cycle can reset, leading to a temporary increase in shedding as new, healthier hair begins to grow.

The Battle Against Superbugs: A Zero-Tolerance Approach to MRSA

Methicillin-resistant Staphylococcus aureus (MRSA) and its counterpart, methicillin-susceptible Staphylococcus aureus (MSSA), are formidable pathogens that demand our utmost respect. On March 21, 2026, I was dismayed to learn that a clinical checklist for MSSA management had failed. When dealing with these aggressive bacteria, there is no room for error.

My protocol for suspected infections is rigid and based on a critical principle: culture first.

1. Obtain a Culture: If a wound is draining, we must culture the fluid. This is non-negotiable.
2. Wait for Results: We do not initiate targeted antimicrobial treatment without a definitive culture and sensitivity report. Guesswork is dangerous.
3. No Mycelium Without Confirmation: While I have seen the powerful effects of certain mushroom-derived compounds (mycelium), applying them to an uncultured wound is inappropriate.
4. Reculture if Necessary: If a patient regresses after an intervention, we stop, reculture the site, and re-evaluate our strategy based on new data.

Assessing the Endometrium: A Critical Step in Patient Safety

When a post-menopausal woman presents with uterine bleeding, assessing the health of the endometrium—the lining of the uterus—is non-negotiable. An ultrasound is our first and most important diagnostic tool. On an ultrasound, we look for the endometrial stripe.

• The Cutoff: A general rule of thumb is that an endometrial stripe of 4 millimeters or less in a post-menopausal woman is considered normal and carries an extremely low (99.9%) risk of cancer (Goldstein, 2015).
• When to Investigate Further: If the stripe is thicker than 4-5 millimeters, or if the patient is bleeding regardless of the thickness, a biopsy is warranted to rule out hyperplasia or cancer. Safety is always the priority.

The Role of Integrative Chiropractic Care in Hormonal Health

Hormonal balance is not just a chemical process; it is deeply intertwined with the body’s entire system. This is where integrative chiropractic care becomes an indispensable part of a comprehensive treatment plan. The nervous system is the body’s master controller, and the endocrine (hormonal) system is in constant communication with it via the hypothalamic-pituitary-adrenal (HPA) axis.

• Nervous System Regulation: Spinal misalignments, or vertebral subluxations, can interfere with the nerve signals traveling between the brain and the endocrine glands. Chiropractic adjustments have been shown to help modulate the sympathetic nervous system and improve heart rate variability (HRV), a key marker of the body’s ability to handle stress (Innes et al., 2016).
• Posture and Musculoskeletal Health: When we optimize testosterone, patients often gain muscle mass. Chiropractic adjustments help correct spinal misalignments, improve posture, and ensure the body can handle a new exercise regimen without injury.
• Enhance Blood Flow and Reduce Inflammation: Proper spinal alignment supports optimal circulation, which is vital for the efficient delivery of hormones. It also helps alleviate physical stress caused by musculoskeletal imbalances, thereby reducing the systemic inflammatory load that can disrupt hormonal function.

By ensuring the spine is properly aligned and the nervous system is functioning optimally, we create an internal environment that is more resilient and better able to regulate itself. As I’ve observed in my clinical practice at PUSH-as-Rx, this provides a stable foundation upon which hormonal therapies can be more effective.

A Call to Action: Change Your Practice, Change Your Life

The fulfilling integrative practice today was built on the principles I’ve shared. It required a commitment to looking deeper, to understanding the interconnectedness of the body’s systems, and to placing the patient’s goals at the very center of care.

This is more than a collection of clinical pearls; it is a paradigm shift. It is an opportunity to improve every aspect of your life and your practice. But it requires action. I invite you to embrace this integrative, patient-centered approach. I promise you it has the power to change your life and your patients’ lives for the better.

References

1. Andersson, C., Shilane, D., Go, A. S., Vittinghoff, E., & Solomon, M. D. (2019). Beta-Blocker Therapy and Cardiac Events Among Patients With Stable Coronary Heart Disease. Journal of the American Heart Association, 8(3), e010788. https://doi.org/10.1161/JAHA.118.010788
2. de Lignières, B., de Vathaire, F., Fournier, S., Al-Azzawi, F., Azen, S. P., Bara, T.,… & Sitruk-Ware, R. (2002). Combined hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 women. Climacteric, 5(4), 332-340. https://doi.org/10.1080/pcn.5.4.332.340
3. Goldstein, S. R. (2015). The role of transvaginal ultrasound in the evaluation of the postmenopausal endometrium. American Journal of Obstetrics and Gynecology, 213(1), 44-53. https://doi.org/10.1016/j.ajog.2015.02.007
4. Innes, S. I., Leboeuf-Yde, C., & Walker, B. F. (2016). The relationship between heart rate variability and the presence of vertebral subluxation: a systematic review. Chiropractic & Manual Therapies, 24(1), 37. https://doi.org/10.1186/s12998-016-0118-4
5. Schindler, A. E. (2011). Progestogen deficiency and endometrial cancer risk. Maturitas, 68(3), 237-240. https://doi.org/10.1016/j.maturitas.2010.12.008
6. Stancil, E. Z., & St. Martin, S. A. (2020). Progesterone. In StatPearls [Internet]. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK558960/
7. Vinogradova, Y., Coupland, C., & Hippisley-Cox, J. (2019). Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ, 364, k4810. https://doi.org/10.1136/bmj.k4810